Nuvation Bio Inc (NUVB) Stock Analysis

Nuvation Bio Inc (NUVB) is a publicly traded company in the HEALTHCARE sector. It trades at $4.89, carries a market capitalization of $1.66B. This page summarizes the public market data, fundamentals, and frequently asked questions for NUVB, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE

Key Metrics

Market Sentiment

Nuvation Bio Inc currently has a Neutral sentiment score of 0.06.

About Nuvation Bio Inc

Nuvation Bio Inc. is a clinical-stage biopharmaceutical company based in New York, focused on the development of innovative therapies for cancer treatment. The company is advancing a robust and diverse pipeline of drug candidates, addressing significant unmet medical needs in the oncology space. With an emphasis on precision medicine and the integration of novel therapeutic approaches, Nuvation Bio seeks to improve patient outcomes while positioning itself for substantial growth within the bi...

GNG Research Analysis

GNG Research scores Nuvation Bio Inc (NUVB) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NUVB.

Frequently Asked Questions

Does NUVB pay dividends?

Nuvation Bio Inc (NUVB) does not currently pay a regular dividend.

What is NUVB's market cap?

Nuvation Bio Inc (NUVB) has a market capitalization of $1.66B with a current stock price of $4.89.